Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

PHASE3CompletedINTERVENTIONAL

Enrollment

286

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Purulent Bacterial Conjunctivitis

Interventions

DRUG

T1225

one drop twice daily (morning and evening) in each eye from Day 0 to Day 2

DRUG

Tobramycin

1 to 2 drops every two hours while awake on Days 0-1, up to 8×/day, then 1 to 2 drops 4 times daily on Days 2-6

Trial Locations (1)

Clermont-Ferrand